Get started
Work

Fri0302 Safety and Efficacy of Rituximab Biosimilar in Systemic Sclerosis: an Italian Multicenter Study

Year: 2019
Type: conference-abstract
DOI: 10.1136/annrheumdis-2019-eular.6961
Authors: Corrado Campochiaro, Giacomo De Luca, Maria Grazia Lazzaroni, Silvia Laura Bosello, Maria De Santis, Adriana Cariddi, Carlo Selmi, Elisa Gremese, Paolo Airò, Marco Matucci-Cerinic, Lorenzo Dagna
Institutions: IRCCS Ospedale San Raffaele, Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, University of Brescia, Agostino Gemelli University Polyclinic, IRCCS Humanitas Research Hospital, Azienda Ospedaliero-Universitaria Careggi, University of Florence
Language: English
Field: Medicine
Open Access status: bronze
Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Bayer, GlaxoSmithKline, Sanofi, Biogen, CSL Behring, Taiho Pharmaceutical, Acceleron, Galecto, Nippon Shinyaku, Apellis Pharmaceuticals, Galápagos, Astellas Pharma, Shionogi, Mitsubishi Tanabe Pharma Corporation, Italfarmaco, Medac, National Institutes of Health, Genentech, Chugai Pharmaceutical, Pharmacyclics
OpenAlex ID: W2949669202
Cites: 1
Cited by: 2
Related to: 10